Ypsomed AG is a Swiss-based company that operates in the Specialty Pharma sector. Founded in 2003, the company specializes in the development and manufacture of innovative injection and infusion systems for self-medication. Ypsomed AG is headquartered in Burgdorf, Switzerland, and has subsidiaries in Europe, Asia, and the United States. The company employs over 1,700 people worldwide and generated revenues of CHF 466 million in 2020.

As a global player in the healthcare industry, Ypsomed AG is committed to sustainability and decarbonisation. The company recognizes the importance of reducing its carbon footprint and has implemented several measures to achieve this goal. One of the key initiatives is the use of renewable energy sources. Ypsomed AG has invested in solar panels and geothermal energy systems to reduce its reliance on fossil fuels. The company has also implemented energy-efficient technologies in its production facilities to reduce energy consumption and greenhouse gas emissions.

Ypsomed AG has also implemented a corporate energy strategy to manage its energy consumption and reduce costs. The company has set targets to reduce its energy consumption and greenhouse gas emissions by 30% by 2025. To achieve this goal, Ypsomed AG has implemented an energy management system that monitors and controls energy consumption in its facilities. The company has also implemented energy-saving measures such as LED lighting, energy-efficient HVAC systems, and optimized production processes.

In addition to its corporate energy strategy, Ypsomed AG has also implemented a corporate Power Purchase Agreement (PPA) to source renewable energy. The company has signed a long-term PPA with a wind farm in Norway to source renewable energy for its production facilities in Switzerland. The PPA provides Ypsomed AG with a stable and predictable source of renewable energy, which helps to reduce its carbon footprint and support the transition to a low-carbon economy.

Ypsomed AG's commitment to sustainability and decarbonisation is also reflected in its product portfolio. The company's injection and infusion systems are designed to optimize drug delivery and reduce waste. Ypsomed AG's autoinjectors and pen systems are designed to be user-friendly and easy to use, which helps to improve patient adherence and reduce the risk of medication errors. The company's infusion systems are designed to be compact and portable, which allows patients to receive treatment at home or on the go, reducing the need for hospitalization.

In conclusion, Ypsomed AG is a Swiss-based company that operates in the Specialty Pharma sector. The company is committed to sustainability and decarbonisation and has implemented several initiatives to reduce its carbon footprint. Ypsomed AG has implemented a corporate energy strategy, a corporate PPA, and has invested in renewable energy sources to reduce its reliance on fossil fuels. The company's commitment to sustainability is also reflected in its product portfolio, which is designed to optimize drug delivery and reduce waste. Ypsomed AG's commitment to sustainability and decarbonisation is a testament to its dedication to improving patient outcomes while minimizing its impact on the environment.